Measure | Study | Distribution-based estimates | |||
---|---|---|---|---|---|
0.2 SD | 0.5 SD | 0.8 SD | SEM | ||
Itch NRS (scale 0–10) | BREEZE-AD1 | 0.42 | 1.04 | 1.67 | 0.88 |
BREEZE-AD2 | 0.43 | 1.09 | 1.74 | 0.89 | |
BREEZE-AD5 | 0.43 | 1.09 | 1.74 | 0.92 | |
Overall | 0.43 | 1.07 | 1.72 | 0.89 | |
Skin pain NRS (scale 0–10) | BREEZE-AD1 | 0.49 | 1.23 | 1.98 | 1.09 |
BREEZE-AD2 | 0.51 | 1.27 | 2.04 | 1.06 | |
BREEZE-AD5 | 0.53 | 1.32 | 2.11 | 1.20 | |
Overall | 0.51 | 1.27 | 2.04 | 1.12 | |
ADSS item 1 (scale 0–4) | BREEZE-AD1 | 0.22 | 0.54 | 0.86 | 0.49 |
BREEZE-AD2 | 0.22 | 0.56 | 0.90 | 0.49 | |
BREEZE-AD5 | 0.24 | 0.60 | 0.95 | 0.52 | |
Overall | 0.23 | 0.57 | 0.90 | 0.50 | |
ADSS item 2 (scale 0–29) | BREEZE-AD1 | 0.93 | 2.34 | 3.74 | 1.39 |
BREEZE-AD2 | 0.46 | 1.15 | 1.85 | 1.31 | |
BREEZE-AD5 | 0.58 | 1.45 | 2.32 | 0.82 | |
Overall | 0.66 | 1.65 | 2.64 | 1.17 | |
ADSS item 3 (scale 0–4) | BREEZE-AD1 | 0.19 | 0.47 | 0.76 | 0.48 |
BREEZE-AD2 | 0.19 | 0.49 | 0.78 | 0.52 | |
BREEZE-AD5 | 0.19 | 0.47 | 0.76 | 0.51 | |
Overall | 0.19 | 0.48 | 0.77 | 0.50 |